安捷伦在SLAS2026展会上展示新一代自动化解决方案 - BioSpace
Agilent Showcases Next‑Generation Automated Solutions at SLAS2026 - BioSpace
生物技术与制药领域的最新动态
Agilent Showcases Next‑Generation Automated Solutions at SLAS2026 - BioSpace
Does Agilent Technologies (NYSE:A) Have A Healthy Balance Sheet? - Yahoo Finance
Agilent Ekes up Ahead of Next Week’s Boston Fair - Baystreet.ca
Agilent Technologies Inc. Showcases Next-Generation Automated Solutions at SLAS2026 - marketscreener.com
Agilent Showcases Next‑Generation Automated Solutions at SLAS2026 - Yahoo Finance
Agilent to Announce First-Quarter Fiscal Year 2026 Financial Results on Feb. 25 - BioSpace
Agilent Technologies : and Virscidian Announce Collaboration to Streamline Access to OpenLab CDS Data in Analytical Studio - marketscreener.com
How is Agilent Technologies' stock performance compared to other healthcare stocks? - MSN
Mediolanum International Funds Ltd Sells 15,620 Shares of Agilent Technologies, Inc. $A - MarketBeat
Monash Innovation Labs and Agilent partner to strengthen applied research in Australia - BioSpectrum Asia
Agilent Technologies, Inc. (A) Stock Analysis: Potential 26.76% Upside Raises Investor Optimism - DirectorsTalk Interviews
Agilent to Announce First-Quarter Fiscal Year 2026 Financial Results on Feb. 25 - Business Wire
Agilent to Announce First-Quarter Fiscal Year 2026 Financial Results on Feb. 25 - FinancialContent
Agilent Technologies price tries to recoup some losses - Forecast today - 02-02-2026 - Economies.com
National Pension Service Acquires 11,841 Shares of Agilent Technologies, Inc. $A - MarketBeat
AE Wealth Management LLC Has $9.54 Million Holdings in Agilent Technologies, Inc. $A - MarketBeat
Chromatograph (Labor): Why Agilent’s Lab Chromatography Systems Are Quietly Powering the Most Impo - AD HOC NEWS
Is Now The Time To Look At Buying Agilent Technologies, Inc. (NYSE:A)? - Yahoo Finance
Mutual of America Capital Management LLC Sells 12,121 Shares of Agilent Technologies, Inc. $A - MarketBeat
Agilent Technologies, Inc. (A) Stock Analysis: A Compelling 25.63% Potential Upside Amid Robust Revenue Growth - DirectorsTalk Interviews